Definite | $10,000,000 | (Aug 22, 2025)
WALLROUND | $4,873,008 | (Aug 22, 2025)
Method AI | $20,000,000 | (Aug 22, 2025)
Certified by Founder
Lodge
Vaxinano
start up
France
- Loos, Hauts-de-France
- 30/10/2024
- Unknown
- $6,503,959
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.
The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
- Industry Biotechnology Research
- Website https://www.vaxinano.com/
- LinkedIn https://www.linkedin.com/company/vaxinano/
Therm | $3,600,000 | (Aug 22, 2025)
SugaROx | $1,341,635 | (Aug 22, 2025)
Molecular You | $5,000,000 | (Aug 22, 2025)
Verdata | $8,000,000 | (Aug 22, 2025)
Agenda Hero | $5,600,000 | (Aug 22, 2025)
The Better Meat Co. | $31,000,000 | (Aug 22, 2025)
CLIKA Inc. | Undisclosed Amount | (Aug 22, 2025)
Grid Aero | $6,000,000 | (Aug 22, 2025)
CVector | $1,500,000 | (Aug 22, 2025)